BACKGROUND
Tuberculosis is a leading cause of death in the world. A new alternative for the treatment of tuberculosis is urgently required, due to the emergence of multidrug resistant Mycobacterium tuberculosis.
OBJECTIVE
There is currently considerable interest in developing potential drugs from